Biomaterials · 2018 · 86 citations · 40 references
PharmacyImmunologyOncologyCancer ImmunologyTumor ImmunologyVaccinologyCancer NanomedicineCancer VaccinesNanomedicinePeptide DeliveryVaccine DeliveryVaccine PlatformsNanoformulated VaccinesNanoparticle Vaccine FormulationsPeptide NanoparticlesPeptide Neoantigen VaccinesPolymer-peptide Conjugates
40
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al. · Science · 2015 · 7.9K citations
Medicine, Immunology, Oncology +17
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder, Vladimir Makarov, Taha Merghoub et al. · New England Journal of Medicine · 2014 · 4.4K citations · Full text
Medicine, Immunology, Oncology +17
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal et al. · Science · 2016 · 3.1K citations · Full text
Life Sciences, Immunology, Oncology +17
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott, Zhuting Hu, Derin B. Keskin et al. · Nature · 2017 · 2.9K citations
Medicine, Immunology, Oncology +12
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Uğur Şahin, Evelyna Derhovanessian, Matthias Miller et al. · Nature · 2017 · 2.5K citations
Medicine, Immunology, Oncology +14